Citation Impact
Citing Papers
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Postmenopausal oestrogen treatment and stroke: a prospective study.
1988
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
2004 Standout
Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries
2003
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Benefits and risks of estrogen replacement therapy
1995
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause
2000
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
The adrenal and polycystic ovary syndrome
2007
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)
2005
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The Heart and Estrogen/Progestin Replacement Study
1999
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application
1995
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Differing Responses in Blood Pressure Over 24 Hours in Normotensive Women Receiving Oral or Transdermal Estrogen Replacement Therapy
1997
The biology of VEGF and its receptors
2003 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Angiogenesis in health and disease
2003 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Continuous estrogen/progestin therapy in menopause
1987
ACTH Stimulation Tests and Plasma Dehydroepiandrosterone Sulfate Levels in Women with Hirsutism
1990
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Transdermal delivery of drugs for the treatment of bone diseases
2000
Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17-estradiol
1997
Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial
2004
Reproductive endocrinologic alterations in female asymptomatic obesity
1989
Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
1999
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Hormone Replacement Therapy Is Associated With Better Glycemic Control in Women With Type 2 Diabetes
2001
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function
1998
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
2003
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
Evidence for Reduced 3β-ol-Hydroxysteroid Dehydrogenase Activity in Some Hirsute Women Thought to Have Poly cystic Ovary Syndrome*
1981
Estrogens for Prevention of Coronary Heart Disease
1996
The Metabolic Syndrome
2008 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients
1986
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Medroxyprogesterone Attenuates Estrogen-Mediated Inhibition of Neointima Formation After Balloon Injury of the Rat Carotid Artery
1996
Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
2005
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Lobo Ra being referenced
Pharmacokinetics of oral 17 beta-estradiol.
1992
Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.
1981
Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
1994
Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism
1992
Estrogen replacement therapy and hypertension.
1985
Polycystic ovary syndrome/hyperandrogenic chronic anovulation.
1995